Knockout of the trcp3 gene causes a recessive neuromotor disease in mice.

Biochem Biophys Res Commun

Departamento de Biología Celular, CINVESTAV-IPN, Ap. postal 14-740, 07000 México, D.F., Mexico.

Published: September 2007

Delta202 mice carry a transgene encoding the SV40 T antigen. Mice homozygous for the transgene develop paralysis and atrophy starting at week 4 and die around week 12. To determine the molecular basis of the neurological syndrome, we identified the transgene insertion site by sequencing two successive nested PCR products amplified with reverse primers from circularized Delta202 mouse DNA fragments generated through XbaI digestion. From the cloned products a consensus 542 bp sequence was obtained, with 409 bp corresponding to the transgene ends surrounding a 133 bp sequence formed by a left 128 bp segment and a right 8 bp segment. The 128 bp sequence matched the chr3:36811347-364811421 sequence corresponding to the promoter region of the trpc3 gene between nucleotides -54 and -53 from the transcriptional start point (+1). Complementary DNA amplification from total brain RNA demonstrated a lack of TRPC3 transcripts in Delta202 mouse brain. The neurologic syndrome of Delta202 mice thus appears to be a monogenic recessive neuromotor disease caused by interruption of the trpc3 gene promoter due to the transgene insertion which in turn blocks the transcription and knocks out TRPC3 calcium channels leading to a failure in the postnatal development of the central nervous system.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.06.150DOI Listing

Publication Analysis

Top Keywords

recessive neuromotor
8
neuromotor disease
8
delta202 mice
8
transgene insertion
8
delta202 mouse
8
trpc3 gene
8
transgene
5
knockout trcp3
4
trcp3 gene
4
gene recessive
4

Similar Publications

In most cases there is a single etiological factor causing neuromotor developmental delay and epilepsy while sometimes more than one gene may be involved. These include the autosomal recessive inherited CAMSAP1 gene, which is associated with cortical developmental malformations such as pachygyria and lissencephaly and the autosomal dominant inherited NBEA gene, which plays crucial roles in vesicle trafficking as well as synapse structure and function. Loss of function of both genes together is a well-known disease mechanism.

View Article and Find Full Text PDF

Background: Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disorder presenting with cerebellar ataxia, sensory-motor axonal neuropathy, oculomotor apraxia, cerebellar atrophy and high alpha-fetoprotein (AFP) serum level. AOA2 is due to coding mutations of the SETX gene, mapped to chromosome 9q34. Seldom noncoding mutations affecting RNA processing have been reported too.

View Article and Find Full Text PDF

Glutamine Supplementation as a Novel Metabolic Therapeutic Strategy for LIG3-Dependent Chronic Intestinal Pseudo-Obstruction.

Gastroenterology

January 2025

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Article Synopsis
  • Researchers discovered a recessive syndrome linked to mutations in the DNA ligase 3 (LIG3) gene that causes chronic intestinal pseudo-obstruction and other neurological issues due to impaired mitochondrial DNA maintenance and energy production.
  • They performed whole transcriptome analysis on patient fibroblasts, finding deregulated genes related to mitochondrial function and extracellular matrix development, and tested l-glutamine supplementation to address energy impairments.
  • Treatment with l-glutamine significantly improved the symptoms of patients with LIG3 mutations, highlighting its potential as a targeted therapy for mitochondrial dysfunction related to this condition.*
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers have developed a new gene expression vector, CPP16, which effectively delivered the human gene responsible for MLIV in preclinical mouse models.
  • * The treatment improved brain function and motor skills, preventing paralysis, although it did not restore retinal thickness despite some positive effects on retinal tissue degeneration.
View Article and Find Full Text PDF

Autosomal recessive pathogenetic variants in the gene cause deficiency of deoxyguanosine kinase activity and mitochondrial deoxynucleotides pool imbalance, consequently, leading to quantitative and/or qualitative impairment of mitochondrial DNA synthesis. Typically, patients present early-onset liver failure with or without neurological involvement and a clinical course rapidly progressing to death. This is an international multicentre study aiming to provide a retrospective natural history of deoxyguanosine kinase deficient patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!